Novo Nordisk puts $255M on the line to bag another obesity asset, turning to EraCal for novel approach
Novo Nordisk puts $255M on the line to bag another obesity asset, turning to EraCal for novel approach
ntaylor
Tue, 01/23/2024 - 07:55
СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *
